David S. Ege
Officer at Seres Therapeutics, Inc. (MCRB)
David S. Ege has filed 9 insider reports with the SEC since February 2022, as officer at Seres Therapeutics, Inc. (MCRB). David S. Ege made no open-market purchases or sales in the last 12 months. In the latest filing, on August 19, 2024, David S. Ege sold 1,128 shares of Seres Therapeutics, Inc. (MCRB) for $948 at an average of $0.84.
- Filings
- 9
- Companies
- 1
- Bought on market
- None
- Sold on market
- $89.1K
Companies where David S. Ege is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Officer | 77,575 | $89.1K | $1.24 | Aug 19, 2024 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Aug 16, 2024-$948MCRBOfficer Ege David S. converted options into 2,969 shares and sold $948 worth of shares (1,128 units at $0.84), increasing direct ownership by 2% to 77,575 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- May 15, 2024-$1,025MCRBEge David S. converted options into 2,968 shares and sold $1,025 worth of shares (1,090 units at $0.94), increasing direct ownership by 3% to 75,734 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Feb 16, 2024-$5,411MCRBEge David S. converted options into 11,875 shares and sold $5,411 worth of shares (5,010 units at $1.08), increasing direct ownership by 10% to 73,856 unitsForm 4Grant or awardExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Oct 30, 2023-$5,489MCRBEge David S. converted options into 11,361 shares and sold $5,489 worth of shares (4,066 units at $1.35), increasing direct ownership by 12% to 66,991 unitsForm 4Grant or awardExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Apr 28, 2023-$36.5KMCRBSEC Form 4 filed by Ege David S.Form 4Grant or awardOpen-market sale10b5-1 plan
- Feb 3, 2023MCRBSEC Form 4 filed by Ege David S.Form 4Grant or award
- Oct 31, 2022-$39.7KMCRBSEC Form 4: Ege David S. was granted 20,000 shares and sold $39,745 worth of shares (5,012 units at $7.93) as part of a pre-agreed trading plan, increasing direct ownership by 47% to 46,734 unitsForm 4Grant or awardOpen-market sale10b5-1 plan
- Jul 5, 2022MCRBSEC Form 4: Ege David S. was granted 31,746 sharesForm 4Grant or award
Compare David S. Ege with
- David S. Ege vs Kelly Brady1 shared
- David S. Ege vs Eric D. Shaff1 shared
- David S. Ege vs Matthew R Henn1 shared
- David S. Ege vs Thomas DesRosier1 shared
- David S. Ege vs Willard H Dere1 shared
- David S. Ege vs Dennis A Ausiello1 shared
Other insiders at the same companies
- Matthew R HennMCRB
- Thomas DesRosierMCRB
- Eric D. ShaffMCRB
- Kelly BradyMCRB
- Dennis A AusielloMCRB
- Richard N KenderMCRB
- Kurt GravesMCRB
- Willard H DereMCRB
- Marella ThorellMCRB
- Claire FraserMCRB
- Robert L. RosielloMCRB
- Stephen BerensonMCRB
- Teresa L. YoungMCRB
- Paul BiondiMCRB
- Lisa von MoltkeMCRB
- Hans-Juergen WoerleMCRB
Questions about David S. Ege
- What is David S. Ege's role at Seres Therapeutics, Inc.?
- David S. Ege reports to the SEC as officer at Seres Therapeutics, Inc. (MCRB), according to the latest filing on August 19, 2024.
- How many shares does David S. Ege own?
- After the latest filing that states it, David S. Ege directly owned 77,575 shares of Seres Therapeutics, Inc. (MCRB). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has David S. Ege bought or sold stock recently?
- The most recent open-market sale was on August 16, 2024: sold 1,128 shares of Seres Therapeutics, Inc. (MCRB) for $948 at an average of $0.84.
- How do I get alerts when David S. Ege files?
- Follow David S. Ege on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by David S. Ege (SEC CIK 0001829360). Totals count each trade once, skipping amendments whose original is on file, from Feb 9, 2022 on. View on SEC EDGAR · Get this as JSON